Krystal Biotech Operating Expenses Growth & History (KRYS)

Krystal Biotech's operating expenses was $227.8M for fiscal 2025.

View full Krystal Biotech company overview

Krystal Biotech annual operating expenses history

Krystal Biotech annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31$227.8M$3.1M+1.36%
20242024-12-31$224.8M$64.5M+40.20%
20232023-12-31$160.3M$15.1M+10.41%
20222022-12-31$145.2M$76.9M+112.66%
20212021-12-31$68.3M$35.3M+106.90%
20202020-12-31$33.0M$10.9M+49.45%
20192019-12-31$22.1M$10.2M+85.31%
20182018-12-31$11.9M$7.1M+149.71%
20172017-12-31$4.8M$3.6M+317.50%
20162016-12-31$1.1M

Krystal Biotech operating expenses trends

Over the last five fiscal years, Krystal Biotech's operating expenses increased from $33.0M to $227.8M, a change of $194.8M. The latest reported quarter, Q2 2026, shows $60.8M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Krystal Biotech source filings ↗

Community posts

It’s quiet here.

No posts about KRYS yet. Start the conversation.

Write the first post